Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways

Immunol Res. 2023 Dec;71(6):800-813. doi: 10.1007/s12026-023-09400-5. Epub 2023 Jun 9.

Abstract

Ubiquitination (or ubiquitylation) and de-ubiquitination, which are both post-translational modifications (PTMs) of proteins, have become a research hotspot in recent years. Some ubiquitinated or de-ubiquitinated signaling proteins have been found to promote or suppress innate immunity through Toll-like receptor (TLR), RIG-like receptor (RIG-I-like receptor, RLR), NOD-like receptor (NLR), and the cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS)-STING pathway. This article aimed to provide a review on the role of ubiquitination and de-ubiquitination, especially ubiquitin ligase enzymes and de-ubiquitinating enzymes, in the above four pathways. We hope that our work can contribute to the research and development of treatment strategies for innate immunity-related diseases such as inflammatory bowel disease.

Keywords: De-ubiquitinating enzymes; Innate immunity; Signal pathway; Ubiquitin ligase enzymes.

Publication types

  • Review

MeSH terms

  • Immunity, Innate
  • Ligases
  • NLR Proteins*
  • Toll-Like Receptors
  • Ubiquitin*

Substances

  • Ubiquitin
  • NLR Proteins
  • Ligases
  • Toll-Like Receptors